With a market cap of $10.7 billion, Insulet Corporation (PODD) is a top medical device company specializing in tubeless insulin delivery systems for people with diabetes. Headquartered in Acton, Massachusetts, the company is best known for its flagship Omnipod platform, a wearable, automated insulin delivery system designed to simplify diabetes management for patients with Type 1 and Type 2 diabetes.
Shares of PODD have significantly trailed the broader market over the past 52 weeks. PODD stock has plunged 51.8% over this period, while the broader S&P 500 Index ($SPX) has gained 27.9%. Moreover, shares of PODD are down 45.5% on a YTD basis, compared to SPX’s 9.2% rise.